newsfilter
← Earnings
Earnings Releases·

iRhythm Holdings — Third Quarter 2026 Earnings Summary

  • Revenue grew 14.9% year-over-year to $221.6 million, while adjusted net income turned positive at $27.8 million ($0.82 per share) compared to a $2.0 million loss in the prior year period.
  • Fiscal 2026 guidance was raised to $890–$895 million in revenue and a 15.5%–16.0% adjusted EBITDA margin, incorporating approximately $16 million in expected VitalConnect contribution.
  • Completed the acquisition of VitalConnect on October 5, 2026, to expand the mobile cardiac telemetry portfolio, though GAAP net loss widened to $29.9 million due to $49.8 million in litigation settlements and $6.6 million in transformation costs.
  • Free cash flow was negative $11.5 million for the quarter, and the company closed a new $300 million senior secured revolving credit facility to support long-term growth.
Company
IRHYTHM HOLDINGS INC
Sector
Healthcare
Industry
Medical Devices